Skip to content
Open access

Pep2Mol: 3D Molecule Generation Targeting Protein-Protein Interfaces with Diffusion Models

Jun 2026 · bioRxiv · 0 citations · 45 references
Biology Medicine

TL;DR

P Pep2Mol is introduced, a diffusion-based generative model for 3D molecule design that targets orthosteric PPI sites by explicitly incorporating binding peptides or proteins as structural guidance, moving beyond conventional pocket-conditioned generation.

Abstract

Protein-protein interactions (PPIs) are central to biological processes. Designing small molecules that modulate dysregulated PPIs holds strong promise for targeting undruggable proteins. However, existing structure-based drug design approaches focus on well-defined small-molecule binding pockets and struggle to generalize to large, shallow, and chemically complex PPI interfaces. Here, we introduce Pep2Mol, a diffusion-based generative model for 3D molecule design that targets orthosteric PPI sites by explicitly incorporating binding peptides or proteins as structural guidance, moving beyond conventional pocket-conditioned generation. To enable model development and benchmarking, we curate a large-scale, high-quality dataset of 10,956 experimentally resolved protein complex structure pairs, each pairing an orthosteric competitive ligand with a protein binder at overlapping receptor interfaces. Pep2Mol integrates two SE(3)-equivariant graph neural networks that encode protein–ligand and protein–peptide interactions respectively, and fuses these representations via attention-based conditioning to jointly guide the diffusion trajectory. Extensive evaluations demonstrate that Pep2Mol generates chemically valid ligands with state-of-the-art binding affinities, providing a strong foundation for small-molecule inhibitor design against challenging PPI interfaces.

Read PDF

Similar papers

Open access Jun 2026

Zero-shot design of drug-binding proteins via neural iterative selection−expansion

This work used its strategy, termed neural iterative selection–expansion (NISE), to design proteins that, using different folds, specifically bind to two chemically distinct small-molecule drugs, exatecan and apixaban, with success rates of 100%, respectively.

Benjamin Fry, Kaia Slaw, Nicholas F. Polizzi · 7 citations · ⚡1
Review Open access Jun 2026

Targeting the Undruggable: Deep Learning-Driven Design of Peptide Therapeutics in Cancer

How advances in artificial intelligence and computational modeling may reshape the rational design of next-generation peptide therapeutics is explored and an integrated experimental–computational framework is proposed to facilitate the development of clinically actionable candidates is proposed.

Ha Thi Ngoc Nguyen, B. Le, Nhung Thi Hong Van et al. · 0 citations
Open access Jul 2026

BiMba: using Vision Mamba to predict protein sites that bind other proteins

A state-space–driven deep learning framework that leverages the efficient long-range modeling capability of the Vision Mamba architecture to learn from three-dimensional protein surfaces represented as two-dimensional geometric or physicochemical grids, establishing state-space models as efficient, interpretable, and s...

Azam Shirali, Parshatd Govindasamy, Vitalii Stebliankin et al. · 0 citations
Open access Jun 2026

DruGUI 2.0: mapping protein druggability with probe-based molecular dynamics

DruGUI 2.0 is developed to facilitate the search for druggable sites while allowing for proteins’ conformational flexibility, and complements, and benefits from, the vast collection of protein sequence, structure, and dynamics analyses modules accessible in ProDy.

Carlos Ventura, J. Y. Lee, Anthony T. Bogetti et al. · 0 citations
Open access Jun 2026

Hybrid Approach to Protein–Protein Complex Affinity Prediction Based on Language Models and Molecular Dynamics

HyBind-NN is developed, a multimodal graph neural network that integrates protein language models (PLMs) with 3D structural and dynamic datasets to predict protein–protein and protein–peptide affinity, and it is demonstrated that combining ESM-2 sequence embeddings with precise 3D Voronoi spatial geometry enables accur...

E. A. Bogdanova, A. Chernukhin, Alexey K. Shaytan · 0 citations
Jul 2026

Generating Developable 3D Molecules via Pocket-Conditioned Diffusion and Property-Aware Optimization

Drug discovery and development is time-consuming and resource-intensive, motivating computational approaches such as diffusion models for de novo drug design. Many such models follow the structure-based drug design (SBDD) paradigm, generating molecules to fit a target binding pocket. However, existing diffusion-based S...

Ruoxi Gao, Jiangweizhi Peng, Ziqi Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.